Author
University of LiègeORCID 0000-0001-7025-6106Unclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Tomáš Venit, Jérémy Blavier, Sibusiso B. Maseko…·Piergiorgio Percipalle
This paper designs nanobodies against SARS-CoV-2 Nsp9 to inhibit viral replication, showing effectiveness against multiple variants in HEK293-ACE2 cells.
Philipp Trepte, Christopher Secker, Julien Olivet…·Erich E. Wanker
The paper presents an AI-guided pipeline for PPI drug discovery, identifying a SARS-CoV-2 inhibitor by combining experimental assays, machine learning, and virtual screening.
Veronika Young, Bushra Dohai, Thomas C. A. Hitch…·Pascal Falter‐Braun
The paper identifies a gut microbiome meta-interactome map showing how bacterial effectors modulate human immunity and are enriched in Crohn's disease.
Dae‐Kyum Kim, Benjamin Weller, Chung‐Wen Lin…·Pascal Falter‐Braun
The paper maps binary SARS-CoV-2 protein interactions with host proteins, identifying key processes like immune signaling and ubiquitination, and suggests therapeutic targets.
Charlotte Vandermeulen, Tina M. O’Grady, Jérôme Wayet…·Jean‐Claude Twizere
This study shows that Tax and HBZ, viral oncoproteins, alter mRNA splicing in T-cells by interacting with spliceosome components, leading to changes in cancer-related genes.